Achieve Life Sciences Inc.

ACHV | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.37

+$0.32 (+3.98%)

Sep 22, 2026, 2:41 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $826.4M

Enterprise Value $654.05M

Beta 2.25

Average Volume 1.65M

Shares Outstanding (Diluted) 93.51M

Shares Change YoY 169.6%

Institutional Ownership 40.32%

Exchange NASDAQ

ISIN US0044685008

Price Performance

Price Change 1M 0.8%

Price Change 3M 60.7%

Price Change 6M 185.5%

Price Change YTD 62.0%

Price Change 1Y 172.9%

Price Change 3Y 84.6%

Price Change 5Y -14.1%

1M CAGR (ann.) 21.1%

1Y CAGR (ann.) 180.5%

5Y CAGR (ann.) 1.4%

All-Time CAGR -40.1%

Valuation

PE Ratio -5.19

Forward PE N/A

PEG Ratio 0.24

Forward PEG 0.10

PS Ratio N/A

Forward PS 23.50

PB Ratio -56.31

P/FCF Ratio -17.57

P/Adj. FCF Ratio -14.51

P/OCF Ratio -16.10

EV/Sales N/A

EV/EBIT -5.79

EV/EBITDA -5.80

EV/FCF -13.91

Earnings Yield -19.3%

FCF Yield -5.7%

Adj. FCF Yield -6.9%

Financial Health

Net Cash $172.36M

Total Debt $14.95M

Cash & Short-Term Investments $187.3M

Total Assets $190.44M

Current Ratio 0.95

Quick Ratio 0.95

Debt / Equity Ratio -1.02

Debt / EBITDA -0.13

Debt / FCF -0.32

OCF / Debt -3.15

Interest Coverage -58.63

Altman Z-Score -2.14

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -21.1%

Returns

Return on Assets -59.9%

Return on Equity -892.1%

Return on Invested Capital -21425.7%

Return on Capital Employed 807.4%

Return on Tangible Assets -60.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -54.5%

EPS CAGR 3Y -16.0%

EPS CAGR 5Y 25.5%

EPS CAGR 10Y 50.1%

FCF CAGR 3Y -38.5%

FCF CAGR 5Y -11.1%

FCF CAGR 10Y -13.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 6

EPS Growth Next 3Y 62.1%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.20

EPS Growth Est (next Q) -28.6%

Revenue Est (next Q) $10.65M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $14

Price Target Upside 73.9%

Cash Flow

Operating Cash Flow $-47.02M

Free Cash Flow $-47.04M

Adj. Free Cash Flow $-56.95M

FCF Per Share -$0.50

OCF Per Share -$0.50

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-111K

Operating Income $-58.28M

EBITDA $-112.82M

Net Income $-114.04M

EPS (Diluted) -$1.55

Revenue / Employee N/A

Profit / Employee $-4.07M

Employees 28